🌍·6h agoRegulatory
Ανάκληση των παρτίδων 17270129, 17363725, 17385132, του φαρμακευτικού προϊόντος VISIPAQUE INJ.SOL 625 MG(320MG I)/ML BTx1 USB BOTTLE x 100ml
Publisher
E
EOF Greece
Greece
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on eof.gr
Leave the platform to read the original full article on the publisher site.
Source: EOF Greece
Scope: Regulatory
Related coverage
More related coverage
MHRA UK·3h ago
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
EOF Greece·6h ago
Ανάκληση της Άδειας Χονδρικής πώλησης φαρμάκων για Ανθρώπινη Χρήση στο πρατήριο της εταιρείας ΕΝΟΡΑΣΙΣ ΑΕ
EOF Greece·7h ago
Έντυπα & Διαδικασίες Τμήματος Τιμολόγησης
Certara·2h ago